206 related articles for article (PubMed ID: 8396769)
1. Comparison of calcipotriol with selected metabolites and analogues of vitamin D3: effects on cell growth regulation in vitro and calcium metabolism in vivo.
Binderup L
Pharmacol Toxicol; 1993; 72(4-5):240-4. PubMed ID: 8396769
[TBL] [Abstract][Full Text] [Related]
2. Calcipotriol: a new drug for topical psoriasis treatment.
Kragballe K
Pharmacol Toxicol; 1995 Oct; 77(4):241-6. PubMed ID: 8577633
[TBL] [Abstract][Full Text] [Related]
3. Treatment of psoriasis with calcipotriol and other vitamin D analogues.
Kragballe K
J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):1001-8. PubMed ID: 1479078
[TBL] [Abstract][Full Text] [Related]
4. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro.
Colston KW; Chander SK; Mackay AG; Coombes RC
Biochem Pharmacol; 1992 Aug; 44(4):693-702. PubMed ID: 1324683
[TBL] [Abstract][Full Text] [Related]
5. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo.
Binderup L; Bramm E
Biochem Pharmacol; 1988 Mar; 37(5):889-95. PubMed ID: 2830885
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cell growth, c-myc mRNA, and 1,25-(OH)2 vitamin D3 receptor in C3H/10T1/2 mouse embryo fibroblasts by calcipotriol and 1,25-(OH)2 vitamin D3.
Trydal T; Lillehaug JR; Aksnes L; Aarskog D
Acta Endocrinol (Copenh); 1992 Jan; 126(1):75-9. PubMed ID: 1310564
[TBL] [Abstract][Full Text] [Related]
7. Biologic activity of dihydroxylated 19-nor-(pre)vitamin D3.
Bouillon R; Sarandeses LA; Allewaert K; Zhao J; Mascareñas JL; Mouriño A; Vrielynck S; de Clercq P; Vandewalle M
J Bone Miner Res; 1993 Aug; 8(8):1009-15. PubMed ID: 8213251
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D3 and skin diseases.
Kragballe K
Arch Dermatol Res; 1992; 284 Suppl 1():S30-6. PubMed ID: 1337425
[TBL] [Abstract][Full Text] [Related]
9. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
10. Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation.
Takahashi H; Ibe M; Kinouchi M; Ishida-Yamamoto A; Hashimoto Y; Iizuka H
J Dermatol Sci; 2003 Feb; 31(1):21-8. PubMed ID: 12615360
[TBL] [Abstract][Full Text] [Related]
11. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
Svendsen ML; Daneels G; Geysen J; Binderup L; Kragballe K
Pharmacol Toxicol; 1997 Jan; 80(1):49-56. PubMed ID: 9148283
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of 1 alpha,23,25,26-tetrahydroxyvitamin D3.
Ishizuka S; Reichel H; Norman AW
Arch Biochem Biophys; 1987 Apr; 254(1):188-95. PubMed ID: 3034157
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D3 and calcipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes.
Koli K; Keski-Oja J
J Invest Dermatol; 1993 Nov; 101(5):706-12. PubMed ID: 8228332
[TBL] [Abstract][Full Text] [Related]
14. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.
Norman AW; Bouillon R; Farach-Carson MC; Bishop JE; Zhou LX; Nemere I; Zhao J; Muralidharan KR; Okamura WH
J Biol Chem; 1993 Sep; 268(27):20022-30. PubMed ID: 8397195
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism.
Zhou JY; Norman AW; Akashi M; Chen DL; Uskokovic MR; Aurrecoechea JM; Dauben WG; Okamura WH; Koeffler HP
Blood; 1991 Jul; 78(1):75-82. PubMed ID: 1648977
[TBL] [Abstract][Full Text] [Related]
16. Calcipotriol (MC 903): pharmacokinetics in rats and biological activities of metabolites. A comparative study with 1,25(OH)2D3.
Kissmeyer AM; Binderup L
Biochem Pharmacol; 1991 Jun; 41(11):1601-6. PubMed ID: 2043150
[TBL] [Abstract][Full Text] [Related]
17. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
[TBL] [Abstract][Full Text] [Related]
18. Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses.
Norman AW; Okamura WH; Farach-Carson MC; Allewaert K; Branisteanu D; Nemere I; Muralidharan KR; Bouillon R
J Biol Chem; 1993 Jul; 268(19):13811-9. PubMed ID: 8390978
[TBL] [Abstract][Full Text] [Related]
19. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
[TBL] [Abstract][Full Text] [Related]
20. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
